KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Shares Issued (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 16 years of Shares Issued data on record, last reported at $85.2 million in Q4 2025.

  • For Q4 2025, Shares Issued rose 826.34% year-over-year to $85.2 million; the TTM value through Dec 2025 reached $107.9 million, up 422.41%, while the annual FY2025 figure was $107.9 million, 422.41% up from the prior year.
  • Shares Issued reached $85.2 million in Q4 2025 per JAZZ's latest filing, up from $733000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $85.2 million in Q4 2025 and bottomed at $17000.0 in Q3 2024.
  • Average Shares Issued over 5 years is $20.4 million, with a median of $13.1 million recorded in 2021.
  • Peak YoY movement for Shares Issued: crashed 99.69% in 2024, then soared 4211.76% in 2025.
  • A 5-year view of Shares Issued shows it stood at $18.2 million in 2021, then skyrocketed by 66.15% to $30.2 million in 2022, then plummeted by 70.64% to $8.9 million in 2023, then increased by 3.87% to $9.2 million in 2024, then soared by 826.34% to $85.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $85.2 million in Q4 2025, $733000.0 in Q3 2025, and $10.5 million in Q2 2025.